-
Iindaba Ezivuyisayo | IZiko leMveliso ye-Semaglutide ye-API enkulu kunazo zonke yaseChina idlula ukuhlolwa kwe-US FDA
Ukususela ngo-Agasti 26 ukuya ku-Agasti 30, 2024, indawo yokuvelisa i-peptide ye-JYMed, i-Hubei JX Bio-Pharmaceutical Co., Ltd., iphumelele ngempumelelo uhlolo lwendawo olwenziwe yi-US Food and Drug Administration (FDA). Uhlolo lwabandakanya iindawo eziphambili ...Funda ngokugqithisileyo -
2024 CPHI Milan uMboniso woPhando lweZamayeza Recap
01. Umboniso waMagqabantshintshi Ngomhla we-8 ka-Okthobha, uMboniso weHlabathi we-CPHI weHlabathi liphela woShishino waqala eMilan. Njengomnye weziganeko ezibaluleke kakhulu zonyaka kwishishini lehlabathi lamachiza, litsale abathathi-nxaxheba abavela kumazwe angama-166 kunye nemimandla. Ngokungaphezulu...Funda ngokugqithisileyo -
Iindaba Ezivuyisayo | I-JYMed's Liraglutide API iFumana iSatifikethi seWC
Ngomhla we-12 ku-Okthobha, ngo-2024, i-JYMed's Liraglutide API yafumana isatifikethi esiBhaliweyo sokuQinisekisa (WC), esiphawula inyathelo elibalulekileyo ekuthumeleni ngempumelelo i-API kwimarike ye-EU. I-WC (iSiqinisekiso esiBhaliweyo)...Funda ngokugqithisileyo -
Iindaba ezimnandi: I-JYMed's Leuprorelin Acetate Ipasile uHlolo lokuBhaliswa kweziyobisi
Kungekudala, i-JYMed Technology Co., Ltd. yazisa ukuba i-Leuprorelin Acetate, eveliswe yi-subsidiary yayo i-Hubei JX Bio-Pharmaceutical Co., Ltd., iphumelele ngempumelelo ukuhlolwa kokubhaliswa kweziyobisi. Intengiso yeZiyobisi yokuqala...Funda ngokugqithisileyo -
Sivuyisana ne-JYMed's Tirzepatide igqibezela ukufayila kwe-US-DMF
I-JYMed Technology Co., Ltd. iyavuya ukwazisa ukuba imveliso yayo, i-Tirzepatide, igqibe ngempumelelo ukubhaliswa kweFayile eyi-Drug Master (DMF) kunye ne-US FDA (Inombolo ye-DMF: 040115) kwaye ifumene i-Acknowl ye-FDA ...Funda ngokugqithisileyo -
UJYMed uya kwiPCT 2024 eShanghai
I-PCT2024 Personal Care Technology Summit & Exhibition yisiganeko esinempembelelo kakhulu kwingingqi ye-Asia-Pacific, igxininise ekutshintshisweni kwetheknoloji kunye nemiboniso kwi-industry imveliso yokhathalelo lomntu.Funda ngokugqithisileyo -
I-JYMed Peptide ikumema ukuba uzimase uMboniso weZithako zezithambiso eKorea ka-2024
Indawo: Korea International Exhibition Centre Umhla: Julayi 24-26, 2024 Ixesha: 10:00 AM - 5:00 PM Idilesi: COEX Exhibition Centre Hall C, 513 Yeongdong-daero, Gangnam-gu, Seoul, 06164 In-cosmetics a Iqela elikhokelayo lemiboniso yezizwe ngezizwe kwisithako sokhathalelo lobuqu...Funda ngokugqithisileyo -
Ibhulethini yoMmiselo omtsha
1. Imithetho emitsha yokuBhaliswa kwe-FDA kwi-US Cosmetics Cosmetics Ngaphandle koBhaliso lwe-FDA iyakuValwa ekuthengisweni.NgokoMthetho we-Modernization of Cosmetics Regulation Act ka-2022, esayinwe nguMongameli u-Biden nge-29 kaDisemba 2022, zonke izithambiso ezithunyelwa eUnited States kufuneka zibe yi-FDA. -bhalisa...Funda ngokugqithisileyo -
Isaziso seHolide yoMthendeleko waseNtwasahlobo
Nceda uxelelwe ukuba i-ofisi yethu iya kuvalwa ukususela ngomhla we-4 kuFebruwari ukuya ku-Feb.18 ngenxa yoMnyhadala weNtwasahlobo. Naziphi na iiodolo ziya kwamkelwa kodwa aziyi kuqhutyelwa phambili de kube nguFeb.19, usuku lokuqala lomsebenzi emva koMnyhadala waseNtwasahlobo. Uxolo ngayo nayiphi na ingxaki ebangelwe.Funda ngokugqithisileyo -
2023 I API 88 yaseTSHAYINA
Ulwazi malunga ne-JYMed ngo-2023 API CHINA 【kwisiza】 Ngaphantsi kobunkokeli be-Vice General Manager Zhi Qin, i-Shenzhen JYMed Technology Co.,Ltd. (emva koku kubhekiselwa kuyo njenge-JYMed) ithathe inxaxheba kulo mboniso mkhulu. I-JYMed ibonise iimveliso eziluncedo iSemaglutide, iLiraglutide, iTirzepatide, iO...Funda ngokugqithisileyo -
Wamkelekile ukudibana nathi kumboniso we-API eQindao China JYMed stock: N4K32
Funda ngokugqithisileyo -
I-JYMed idibene nawe ePCHi
Emva kweminyaka emibini yolindelo, i-2023 China International Cosmetics Personal and Home Care Raw Materials Exhibition (PCHi) yayibanjelwe eGuangzhou Canton Fair Complex ngoFebruwari 15-17, 2023. I-PCHi ngumboniso wezorhwebo wamazwe ngamazwe okhonza izithambiso zehlabathi, ngokwe ...Funda ngokugqithisileyo -
I-Semeglutide API ye-Shenzhen JYMed yamkelwe liqela lokuqala le-NMPA yasekhaya kwaye ibhaliswe kwi-US FDA (i-DMF No. 036009) enesimo "A".
NgoMeyi ka-2022, i-Shenzhen JYMed Technology Co., Ltd. (emva koku kuthiwa yi-JYMed peptide) ingenise isicelo sokubhaliswa kwe-semaglutide API kwi-US Food and Drug Administration (FDA) (inombolo yobhaliso ye-DMF: 036009), Idlulile. uphononongo lwemfezeko, kunye nemo yangoku...Funda ngokugqithisileyo -
Iipeptide zeCopper: Izibonelelo zoKhathalelo lwesikhumba kunye neNwele kunye nendlela yokuzisebenzisa
Sibandakanya iimveliso esicinga ukuba abafundi bethu baya kuzifumana ziluncedo. Sinokufumana ikhomishini encinci ukuba uthenga ngekhonkco kweli phepha. Le yinkqubo yethu. Iipeptides zivela ngokwendalo ii-amino acids ezinceda ukuvelisa icollagen kunye ne-elastin, izihlunu ezibini ezinxibelelanayo ezinoxanduva ...Funda ngokugqithisileyo -
I-Ozempic (Semaglutide) Isitofu: Ukusetyenziswa, i-Side Effects, i-Dosage
U-Erica Prouty, i-PharmD, ngusokhemisti oqeqeshiweyo onceda abaguli ngamayeza kunye neenkonzo zekhemesti eMntla Adams, Massachusetts. Kwizifundo zezilwanyana ezingezona zomntu, i-semaglutide ibonakaliswe ukuba ibangele i-C-cell thyroid tumors kwiigundane. Nangona kunjalo, akucaci ukuba lo mngcipheko udlulela ebantwini....Funda ngokugqithisileyo -
I-Derivatization ye-fatty acids ekufumaneni i-peptide kunye neziyobisi zeprotheni
Enkosi ngokundwendwela i-Nature.com. Inguqulelo yesikhangeli oyisebenzisayo inenkxaso enyiniweyo yeCSS. Ngowona mava angcono, sicebisa ukuba usebenzise isikhangeli esihlaziyiweyo (okanye uvale iModi yokuThelela kwi-Internet Explorer). Okwangoku, ukuqinisekisa inkxaso eqhubekayo, siya kunika isayithi ngaphandle kwe ...Funda ngokugqithisileyo -
Ichiza leKlasi lokuqala le-JYMed lenze inkqubela phambili ebonakalayo, iLaipushutai kulindeleke ukuba ibe ngumgca wokuqala wamachiza e-UC.
NgoJuni 29, i-2017, ukuphuhliswa kweLaipushutai, iklasi I iyeza ezintsha kunye nophuhliso lwentsebenziswano ye-JYMed kunye ne-Guangzhou Linkhealth Medical Technology Co., Ltd., yenze inkqubela phambili enkulu. Isibhengezo se-IND yechiza samkelwe yi-CFDA. IJYMed kunye neGuangzhou Lin...Funda ngokugqithisileyo -
Iindaba kunye neMisithoICandelo leeMveliso zePeptide e-JYMed ligqithise ngokungenasiphako uhlolo lwendawo oluvela kwi-FDA.
Sivuyisana ngokufudumeleyo neCandelo lethu leeMveliso zePolypeptide ngokuphumelela ngempumelelo kwi-US FDA yokuhlola indawo "engenaziphene"! Ukuphumelela uhlolo lwe-FDA kwindawo ene "zero defects" sisiganeko esikhulu kwimbali yethu yophuhliso lwe-cGMP. Ayithethi nje ukuba i-API yethu ine-obt...Funda ngokugqithisileyo